Jessica Bhathal, MD
Endocrinology, Diabetes & Metabolism · Mobile, ALNPI 1952696247
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in AL, where the typical reported total is $6,650.
Across 344 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$910
- Amgen$635
- AbbVie$329
- Lilly USA, LLC$327
- AstraZeneca$307
- Sanofi-aventis U.S. LLC$296
- plus $3K from 30 others
What the payments were for
- Food & beverage$5,50199%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 67 | $910 |
| Amgen(2 entities) | 43 | $635 |
| AbbVie(2 entities) | 19 | $329 |
| Lilly USA, LLC | 19 | $327 |
| AstraZeneca | 18 | $307 |
| Sanofi-aventis U.S. LLC | 20 | $296 |
| Medtronic(2 entities) | 14 | $283 |
| Boehringer Ingelheim | 15 | $263 |
| Dexcom, Inc. | 22 | $244 |
| Merck | 15 | $222 |
| Xeris Pharmaceuticals, Inc. | 10 | $200 |
| Bayer | 10 | $182 |
| Clarus Therapeutics Inc. | 12 | $171 |
| BETA Bionics, Inc. | 3 | $157 |
| Abbott | 7 | $150 |
| Corcept Therapeutics | 8 | $121 |
| BD | 6 | $119 |
| Radius Health, Inc. | 6 | $98 |
| Amarin Pharma, Inc. | 5 | $96 |
| Insulet Corporation | 4 | $70 |
| Neurocrine Biosciences, Inc. | 2 | $59 |
| Antares Pharma, Inc. | 2 | $36 |
| Ionis Pharmaceuticals, Inc. | 1 | $35 |
| Shire North American Group Inc | 2 | $32 |
| Mannkind Corporation | 2 | $29 |
| Ultragenyx Pharmaceutical Inc. | 2 | $26 |
| Chiesi USA, Inc. | 1 | $20 |
| Rhythm Pharmaceuticals, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
| Rochester Medical Corporation | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Pfizer | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,557 in reported general payments places this provider in the 45th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
See all endocrinology, diabetes & metabolism providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Mobile
- Wilburn BoltonMobile$52K
- Anita KemmerlyMobile$13K
- Michael DavisMobile$12K
- Heather FishelMobile$11K
- Michael GalitzMobile$10K
- Jocelyn HewittMobile$9K
- Huey McDanielMobile$8K
- Stephen DavisMobile$7K
- Ross del FierroMobile$6K
- Neil SchaffnerOpelika$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.